Roy R. Lobb
Vertrieb & Marketing bei PartsSource, Inc.
Profil
Roy R.
Lobb was the founder of Mercator Therapeutics, Inc. (founded in 2009) where he held the title of Chairman & Chief Scientific Officer from 2009 to 2012.
He was also the founder of Avila Therapeutics, Inc. (founded in 2007) where he served as a Director from 2009 to 2010.
Dr. Lobb is also the founder of Aleta Biotherapeutics, Inc...
Dr. Lobb's current job is Senior Director-Inside Sales at PartsSource, Inc. since 2013.
He is also a Venture Partner at Advent Venture Partners LLP since 2015.
Dr. Lobb's former jobs include being a Principal at Biogen MA, Inc., a Consultant at Biogen, Inc., a Consultant at Alnylam Pharmaceuticals, Inc., and a Principal at Abingworth Management, Inc.
Aktive Positionen von Roy R. Lobb
| Unternehmen | Position | Beginn |
|---|---|---|
PartsSource, Inc.
 PartsSource, Inc. Medical DistributorsDistribution Services PartsSource, Inc. sells replacement medical parts for hospital equipment. The firm operates proprietary technology platform eliminates friction from the healthcare supply chain by delivering evidence-based decision support and workflow automation. The company was founded by A. Ray Dalton in 2001 and is headquartered in Aurora, OH. | Vertrieb & Marketing | 21.01.2010 |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 01.08.2015 |
Ehemalige bekannte Positionen von Roy R. Lobb
| Unternehmen | Position | Ende |
|---|---|---|
Mercator Therapeutics, Inc.
 Mercator Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mercator Therapeutics develops novel cancer drugs. It is the first biopharmaceutical company to use in vivo phage display technology systematically to develop novel cancer drugs. The company was founded by Wadih Arap, Renata Pasqualini, Roy Lobb, Mark Leuchtenberger, and Christopher Guiffre in 2009 is headquartered in Wellesley, MA. | Gründer | 11.04.2012 |
Aleta Biotherapeutics, Inc.
 Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aleta Biotherapeutics, Inc. engages in the immuno-oncology service that focuses on transforming cellular therapeutics. It allows broad spectrum of cancer indication to be targeted including currently intractable solid tumors. The company was founded by Paul Rennert and Roy Lobb and is headquartered in Natick, MA. | Gründer | - |
| BIOGEN INC. | Corporate Officer/Principal | - |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Biogen MA, Inc.
Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Health Technology |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
Mercator Therapeutics, Inc.
Mercator Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mercator Therapeutics develops novel cancer drugs. It is the first biopharmaceutical company to use in vivo phage display technology systematically to develop novel cancer drugs. The company was founded by Wadih Arap, Renata Pasqualini, Roy Lobb, Mark Leuchtenberger, and Christopher Guiffre in 2009 is headquartered in Wellesley, MA. | Health Technology |
Abingworth Management, Inc.
 Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Finance |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Health Technology |
PartsSource, Inc.
PartsSource, Inc. Medical DistributorsDistribution Services PartsSource, Inc. sells replacement medical parts for hospital equipment. The firm operates proprietary technology platform eliminates friction from the healthcare supply chain by delivering evidence-based decision support and workflow automation. The company was founded by A. Ray Dalton in 2001 and is headquartered in Aurora, OH. | Distribution Services |
Aleta Biotherapeutics, Inc.
Aleta Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aleta Biotherapeutics, Inc. engages in the immuno-oncology service that focuses on transforming cellular therapeutics. It allows broad spectrum of cancer indication to be targeted including currently intractable solid tumors. The company was founded by Paul Rennert and Roy Lobb and is headquartered in Natick, MA. | Commercial Services |
